Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide

  1. Antelo, M.L.
  2. De Las Heras, N.
  3. Porras, J.R.G.
  4. Kerguelen, A.
  5. Raya, J.M.
Revue:
Expert Review of Hematology

ISSN: 1747-4094,  1747-4086

Année de publication: 2015

Volumen: 8

Número: 6

Pages: 819-835

Type: Révision

DOI: 10.1586/17474086.2015.1088779 GOOGLE SCHOLAR
La source de données: Scopus